Age (y) (55 ± 11) y Range: 32 - 68 y Clinical FIGO Stage 3/13 (23%) IIA 1/13 (8%) IB 2/13 (15%) IIB 7/13 (54%) IIIB Histology 13/13 (100%) Squamous Carcinoma

Table 1: Characteristics of 13 patients enrolled into the study.